DIGITAL MEDICINES

Serial Number 87932899
643

Registration Progress

Application Filed
May 23, 2018
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

DIGITAL MEDICINES

Basic Information

Serial Number
87932899
Filing Date
May 23, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
643
Status Date
Aug 13, 2019
Application
Pending
Classes
042

Rights Holder

MODERNATX, INC.

03
Address
325 Binney St.
Cambridge, MA 02142

Ownership History

MODERNATX, INC.

Original Applicant
03
Cambridge, MA

Legal Representation

Attorney
John Francis Ward

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

38 events
Date Code Type Description Documents
Mar 31, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 31, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 31, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 31, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 31, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 30, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 30, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 30, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 30, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 30, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 10, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 10, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 10, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 10, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 10, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 17, 2019 DMCC I DATA MODIFICATION COMPLETED Loading...
Aug 15, 2019 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Aug 13, 2019 PBMR Z WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST Loading...
Aug 13, 2019 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Jul 30, 2019 ALIE A ASSIGNED TO LIE Loading...
Jul 20, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 12, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 11, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 11, 2019 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Mar 18, 2019 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Mar 18, 2019 GNFR O FINAL REFUSAL E-MAILED Loading...
Mar 18, 2019 CNFR R FINAL REFUSAL WRITTEN Loading...
Feb 7, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 6, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 6, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 6, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 6, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 6, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 23, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 29, 2018 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 29, 2018 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 1, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 26, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
scientific research and development in the fields of RNA-based pharmaceuticals, RNA-based medicine, RNA-based biologics, RNA-based biotherapeutics, RNA-based biosimilars and RNA-based therapeutics, namely, selection, preparation, analysis, modification, synthesization and delivery of mRNA by chemical, biological and biochemical means, and none of the foregoing research and development services pertaining to the use of digital technology designed to affect behavior or lifestyle changes or the use of digital technology to monitor dosing compliance or improve health outcomes other than by administration of RNA based pharmaceuticals, RNA-based medicine, RNA-based biologics, RNA-based biotherapeutics, RNA-based biosimilars and RNA-based therapeutics

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MEDICINES"